tiprankstipranks
Trending News
More News >

Immuron Limited Issues New Shares in Compliance with Corporations Act

Story Highlights
Immuron Limited Issues New Shares in Compliance with Corporations Act

Don’t Miss TipRanks’ Half-Year Sale

Immuron Limited ( (AU:IMC) ) just unveiled an update.

Immuron Limited has issued 135,800 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with the relevant provisions of the Corporations Act and confirms there is no excluded information required to be disclosed, indicating a transparent and compliant operational stance.

More about Immuron Limited

Immuron Limited operates in the biotechnology industry and is primarily focused on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.

Average Trading Volume: 108,473

Technical Sentiment Signal: Sell

Current Market Cap: A$14.72M

Learn more about IMC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1